tert-Butyl (3-oxocyclopentyl)carbamate

Catalog No. :
ACPJOD307
CAS No. :
847416-99-3
Molecular Formula :
C10H17NO3
Molecular Weight :
199.25

IUPAC Name:tert-butyl (3-oxocyclopentyl)carbamate

tert-Butyl (3-oxocyclopentyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$87.00Login to see priceIn stockInquiry
10g97%$123.00Login to see priceIn stockIn stock
25g97%$306.00Login to see priceIn stockIn stock
100g97%$1013.00Login to see priceIn stockIn stock
500g97%$4913.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-oxocyclopentyl)carbamate
IUPAC Nametert-butyl (3-oxocyclopentyl)carbamate
MDL No.MFCD09751875
Molecular FormulaC10H17NO3
Molecular Weight199.25
SMILESCC(C)(C)OC(=O)NC1CCC(=O)C1
InChI KeyCLOXAWYNXXEWBT-UHFFFAOYSA-N
Synonym847416-99-3 | tert-Butyl (3-oxocyclopentyl)carbamate | tert-butyl 3-oxocyclopentylcarbamate | 3-(BOC-AMINO)CYCLOPENTANONE | TERT-BUTYL N-(3-OXOCYCLOPENTYL)CARBAMATE | 1-(BOC-AMINO)-3-OXOCYCLOPENTANE | (3-OXO-CYCLOPENTYL)-CARBAMIC ACID TERT-BUTYL ESTER | MFCD09751875 | te
CAS No.847416-99-3
PubChem CID53427213

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPJOD307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSTNF179 route compound structure diagram
    ACSTNF1791154870-59-3 In Stock
  2. Then
  3. ACPJOD307 route product structure diagram
    ACPJOD307847416-99-3 In Stock
Inquiry

2. ACPJOD307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPJOD307 route product structure diagram
    ACPJOD307847416-99-3 In Stock
Inquiry

Comments (0)